New options in insulin therapy
نویسندگان
چکیده
منابع مشابه
New options in insulin therapy.
OBJECTIVE To review the new options in insulin therapy for controlling diabetes mellitus in children and adolescents. SOURCES Articles indexed in PubMed were located using the search terms insulin analogs in children and adolescents and reviewed. Information was also obtained from American Diabetes Association and Sociedade Brasileira de Diabetes consensus documents. SUMMARY OF THE FINDINGS...
متن کاملNew Surgical Options in Myocardial Infarction
Saphenous vein autograft had opened a new erra in revascularization of mycardium in cases with severe angina pectoris. This has attracted the attention of many medical enters so that a rae of 7595% relief of pain has been obtained. 92% of patients have demonstrated sings of cure of choronary iSJChemia and have moved to group 1 from those of group 2, 3, and 4 (dassif[ca,tion of American Heart A...
متن کاملNew Trends in Insulin Therapy
In the last few years, huge progress has been witnessed in the development of new drugs. In insulin therapy, there have also been novelties with the advent of new insulins (insulin analogs) specially designed to elicit better pharmacokinetic and pharmacodynamic properties. New possibilities for insulin delivery are in development, which could spare patients from painful injections. These novelt...
متن کاملNew Systemic Therapy Options for Advanced Sarcomas
The outcome of patients with advanced soft tissue sarcomas (STS) has not improved much during the last decade. Apart from non-pleomorphic rhabdomyosarcoma, adjuvant chemotherapy has no standard role in high risk STS. In metastatic disease little progress has been made, but during recent years much effort has been put into the development of better clinical study protocols, with stratification o...
متن کاملNew insulins and insulin therapy.
The introduction of the so-called 'designer' insulins, the insulin analogues, has offered new opportunities in the clinical management of diabetes. Two additional new entities are close to reaching clinical practice. Linjeta™ (formally called VIAject) is not an analogue but rather a different formulation of human insulin which may give it a more rapid onset of action, potentially even faster th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Jornal de Pediatria
سال: 2007
ISSN: 0021-7557
DOI: 10.2223/jped.1712